An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
Clinical trial NCT02641730 · COMPLETED
Trial details
- NCT number
- NCT02641730
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-15
- Primary completion
- 2017-03-28
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.